Literature DB >> 21292931

Reconstruction of soft-tissue injury associated with lower extremity fracture.

Jeffrey B Friedrich1, Leonid I Katolik, Douglas P Hanel.   

Abstract

Soft-tissue loss associated with lower extremity fracture poses a substantial reconstructive challenge. Following stabilization of life-threatening conditions and bony disruptions, the reconstructive team must address the soft-tissue envelope of the limb. The wound is managed with débridement followed by coverage. Coverage options range from basic to complex and include delayed primary closure, healing by secondary intention, skin grafting, local flap coverage, and distant tissue transfer. The choice of soft-tissue coverage method is based on its ability to provide an environment conducive to fracture healing. Understanding the merits and disadvantages of each reconstructive option helps to avoid undertreatment or overtreatment.

Entities:  

Mesh:

Year:  2011        PMID: 21292931     DOI: 10.5435/00124635-201102000-00003

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  5 in total

1.  Soft tissue and wound management of blast injuries.

Authors:  Andrew J Sheean; Scott M Tintle; Peter C Rhee
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

2.  Early free flap reconstruction of blast injuries with thermal component.

Authors:  J Bakhach; O Abou Ghanem; D Bakhach; E Zgheib
Journal:  Ann Burns Fire Disasters       Date:  2017-12-31

Review 3.  The role of muscle in bone repair: the cells, signals, and tissue responses to injury.

Authors:  Krupa Shah; Zahraa Majeed; Jennifer Jonason; Regis J O'Keefe
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

Review 4.  Harnessing Endogenous Cellular Mechanisms for Bone Repair.

Authors:  Claudia Lo Sicco; Roberta Tasso
Journal:  Front Bioeng Biotechnol       Date:  2017-09-04

5.  Outcomes of tissue reconstruction in distal lower leg fractures: a retrospective cohort study.

Authors:  Emrah Aydogan; Stefan Langer; Christoph Josten; Johannes Karl Maria Fakler; Ralf Henkelmann
Journal:  BMC Musculoskelet Disord       Date:  2020-12-01       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.